DIN 00869953 — MESTINON-SR 180 MG
MESTINON-SR is a tablet (extended-release) of Pyridostigmine marketed by BAUSCH HEALTH, CANADA INC.. The full Pyridostigmine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 00869953
- Brand name
- MESTINON-SR
- Active ingredient
- Pyridostigmine
- Strength
- 180 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Cholinesterase inhibitor (antimyasthenic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Pyridostigmine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02508362 | JAMP PYRIDOSTIGMINE BROMIDE | 60 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 00869961 | MESTINON | 60 MG | TABLET | BAUSCH HEALTH, CANADA INC. | MARKETED |
| 02495643 | RIVA-PYRIDOSTIGMINE | 60 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED |